FEC filings through Sep 30, 2026 · FEC bulk filing data · committee C00388819 · files quarterly
SummaryAt a glance
Why it exists
No statement of purpose found on its site.
Money
$145K raised, $137.4K spent, $17.9K cash on hand (through Sep 30, 2026). Where it comes from
Who funds it
68% from donors giving over $200 · 24% from PACs and other committees · largest donor The Cigna Group Employee PAC, $10K. See who funds it
Where it goes
$127.5K given to candidates and committees, the largest to Across the Aisle PAC ($7.5K) · 45% of its support to Republicans, 31% to Democrats. See where it goes
Lobbying
Pharmaceutical Care Management Association lobbied on 3 issues. See lobbying
Its wordsWhat does this committee say it is for?
No published list of positions
This committee’s site publishes no list of positions we could read, and we found no statement of why it exists. We do not write one for it.
Who it gives toWhich candidates and committees get its money?
Each part reads different filings, so counts and totals can differ.
Party support distribution$72.5K to 56 candidates
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
For candidates $72,500
Republican 45%
Democratic 31%
Other or unresolved 24%
Support by the party of the candidate
Party of the candidate
Candidates
Direct
Independent
Amount
Share
Republican
21
$32,500
$0
$32,500
45%
Democratic
23
$22,500
$0
$22,500
31%
Other or unresolved
12
$17,500
$0
$17,500
24%
Shown support
56
$72,500
$0
$72,500
100%
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Who this PAC gave to$127,500 in 102 payments
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
By recipient
Line 23 contributions by kind and party of recipient
Recipient
Count
Amount
Democratic candidates
23
$22.5K · 18%
Republican candidates
20
$31K · 24%
Other or unresolved candidates
13
$19K · 15%
Other party committees
1
$1K · 0.8%
Other PACs and committees
19
$54K · 42%
All recipients
76
$127.5K
By the candidate’s state
Contributions to candidates by the candidate’s state
State
Candidates
Amount
California
3
$8K
Ohio
6
$6.8K
Missouri
2
$5.5K
Minnesota
3
$5.3K
Montana
1
$5K
Oklahoma
2
$4K
Florida
3
$4K
Rhode Island
2
$3.5K
The largest 8 of 29 states.
Recipients 76
Show candidate activity and the money network
Candidate and election activity as the recipients filed it
Pete Aguilar5 receipts, latest Apr 21, 2026Pete Aguilar for Congress · H2CA31125$7K
Eric Burlison2 receipts, latest Mar 24, 2026Eric Burlison for Congress · H2MO07143$5K
Tim Sheehy3 receipts, latest Aug 21, 2025Tim Sheehy for Montana · S4MT00183$5K
Michelle Fischbach2 receipts, latest Jul 9, 2026Fischbach for Congress · H0MN07091$3.3K
Gabriel F. Amo2 receipts, latest Jul 9, 2026Gabe AMO for Congress · H4RI01265$3K
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Committee money network
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees funding this one
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
William M. Power33 contributions, latest Jul 10, 2026 · SR DIR · PHARMACEUTICAL CARE MANAGEMENT ASSOCIA · WASHINGTON, DC$2,193
A donor who gave several times appears once. The 12 largest donors by total given are listed. In all, 747 itemized contributions were filed this cycle, totaling $88.6K. FEC contributor lists are public records and cannot be used for commercial solicitation.
PACs and other committeesPolitical action committees and other candidates' committees.$35,00024%
CVS Health PAC1 receipt, latest Nov 6, 2025 · Pac (qualified)$5,000
The 4 largest committees by total given are listed. Counted from the givers' own filings, which can run above the total this committee reports.
Unitemized ($200 or less)Donors who have given $200 or less this cycle, so the FEC does not itemize (name) them.$11,5668%
Total reported receipts $145,049
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. Open a source marked + to see who gave. FEC filings through Sep 30, 2026.
Who donated: where they live, their employers and jobs
Where the donors live $88,550 placed by state
Loading the map
Tap or hover over a state, or focus the map and use the arrow keys, to read its total. Ctrl or ⌘ and scroll to zoom.
under $2.8K
$2.8K+
$11K+
$24.9K+
$44.2K+
none
Top states
Top donor states
Name
Amount
District of Columbia740 contributions · 78%
$69,050
Minnesota2 contributions · 11%
$10,000
New York1 contribution · 5.6%
$5,000
Illinois1 contribution · 2.3%
$2,000
Kentucky1 contribution · 1.1%
$1,000
New Jersey1 contribution · 1.1%
$1,000
Massachusetts1 contribution · 0.6%
$500
By the state each contributor wrote on the filing. The FEC aggregates every Schedule A line together, so one committee or organization transfer can account for a whole state. Contributors who have given $200 or less this cycle are not itemized and cannot be placed on a map. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total.
SpendingWhere does the money go?
How the spending splits $137,404 reported
Contributions to candidates and other committeesMoney given to federal candidates, party committees and other PACs.$136,80099.6%
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Sep 30, 2026.
What the payments were for $127,767 itemized
Given to othersContributions to other candidates, party committees, and PACs.$127,50099.8%
Filed as
CONTRIBUTION$127,500
Paid to
Across the Aisle PAC$7,500
Pete Aguilar for Congress$7,000
Katherine Clark Majority Fund$5,500
Moderate Democrats PAC$5,000
New Democrat Coalition Action Fund$5,000
Tim Sheehy for Montana$5,000
Card paymentsPaid to a card processor with no itemisation filed beneath it, so the purchases behind it are not on the record.$2670.2%
Filed as
CREDIT CARD PROCESSING FEE$267
Paid to
Paypal Inc.$267
Total itemized disbursements $127,767
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Sep 30, 2026.
All 106 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
Largest vendors
Largest vendors
Spending over time
$137.4K spent from Jan 2025 to Sep 2026. Most in one report: $44.2K, Jan 1 – Jun 30, 2025.
$137.4K
Jan 2025Sep 2026
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
505 9TH STREET NW, 10TH FLOORWASHINGTON, DC, 20004
Audits and penalties
None published by the FEC
LobbyingWhat does its sponsor lobby on?
What Pharmaceutical Care Management Association lobbies on 2026 reports
Besides giving through its PAC, Pharmaceutical Care Management Association pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Spent on lobbying in 2026
$9.8M
Quarterly reports read
26
Bills it named
49
Topics it lobbied on
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
Health Issuesin 19 report entries · 47 bills named
In its own words
S.1637/H.R 7871;
Medicaid VBPs for Patients Act S. 4323/ H.R. 8143;
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582;
Patients Deserve Price Tags Act S. 2426/H.R. 3164;
Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779;
Patients Before Monopolies Act S.2276/ H.R. 3269;
Eliminating Thickets to Improve Competition Act S. 526;
Pharmacy Benefit Manager Transparency Act S. 882;
Patients Before Middlemen Act S. 927;
Protecting Pharmacies in Medicaid Act S. 1041;
Affordable Prescriptions for Patients Act S. 1095;
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096;
Preserve Access to Affordable Generics and Biosimilars Act S. 1097;
Interagency Patent Coordination and Improvements Act of 2025 S. 1414;
Expedited Access to Biosimilars Act S. 2617;
Reducing Drug Prices for Seniors Act S. 2800;
Pharmacy and Medically Underserved Areas Enhancement Act S. 3345;
PBM Price Transparency and Accountability Act S. 3349;
PBM Disclosure Act S. 3549;
PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822;
Break Up Big Medicine Act S. 4189;
INSLUN Act of 2026 S. 5586;
Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244;
Reducing Drug Prices for Seniors Act H.R. 2214;
Delinking Revenue from Unfair Gouging Act H.R. 4317;
PBM Reform Act H.R. 4409;
Fair Pharmacies for Federal Employees Act H.R. 4570;
Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609;
Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610;
Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837;
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
H.R. 7148;
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895;
PBM Kickback Prohibition Act H.R. 8324;
Great American Healthcare Plan H.R. 9228;
Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486;
Health Data Access, Transparency and Affordability Act H.R. 9117;
Lower Cost, More Transparency Act of 2026 H.R. 9645;
Health Care Price Certainty for All Americans Act H.R. 10369;
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Patients Before Monopolies Act S. 526;
INSLUN Act of 2026 H.R. 1244;
Lower Cost, More Transparency Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Medicaid VBPs for Patients Act S. 2355/H.R. 5582;
Ensuring Community Access to Pharmacist Services Act S. 526;
Break Up Big Medicine Act H.R. 1244;
Delinking Revenue from Unfair Gouging Act H.R. 3164;
Ensuring Community Access to Pharmacist Service Act H.R. 4317;
PBM Kickback Prohibition Act H.R. 8143;
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Advocate on concerns relating to duplication of transparency reporting requirements for pharmacy benefits managers as between Consolidated Appropriations Act of 2025 and DOLs Rule on same;
Monitor relevant committee hearings on PBM legislation and healthcare costs and affordability generally.
Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779;
Patients Before Monopolies Act S. 526;
Pharmacy Benefit Manager Transparency Act S. 882;
Patients Before Middlemen Act S. 927;
Protecting Pharmacies in Medicaid Act S. 2800;
Pharmacy and Medically Underserved Areas Enhancement Act S. 3822;
Break Up Big Medicine Act S. 4189;
INSLUN Act of 2026 S. 5586;
Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244;
Reducing Drug Prices for Seniors Act H.R. 4317;
PBM Reform Act H.R. 4409;
Fair Pharmacies for Federal Employees Act H.R. 6610;
Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148;
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645;
Health Care Price Certainty for All Americans Act H.R. 10369;
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
INSLUN Act of 2026 H.R. 1244;
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Medicare/Medicaidin 4 report entries · 20 bills named
In its own words
S.1637/H.R 7871;
Medicaid VBPs for Patients Act S. 2426/H.R. 3164;
Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244;
Reducing Drug Prices for Seniors Act S. 882;
Patients Before Middlemen Act S. 927;
Protecting Pharmacies in Medicaid Act S. 1041;
Affordable Prescriptions for Patients Act S. 2800;
Pharmacy and Medically Underserved Areas Enhancement Act S. 3345;
PBM Price Transparency and Accountability Act S.4323/ H.R. 8143;
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 5586;
Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 4317;
PBM Reform Act H.R. 6609;
Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148;
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9393;
Lower Costs, More Transparency Act H.R. 9645;
Health Care Price Certainty for All Americans Act H.R. 10369;
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Who did the lobbying
The organization’s own reports give its total lobbying costs, including any firms it hired; each firm reports what this client paid it.
Pharmaceutical Care Management AssociationIts own staff · 4 reports$9.8M
Reported twice a year by the lobbying filer. $96.7K is political giving that also appears in FEC filings.
Democratic Senatorial Campaign Committee$21K
Representative Katherine Clark$12.5K
Governor Roy Cooper$10K
Mr. Josh Turek$10K
Former Representative Mary Peltola$7K
Representative Pete Aguilar$6K
Senator Ruben Gallego$5K
Representative John Mannion$4K
Katherine Clark$3K
Senator Jon Ossoff$3K
Matched by name: these reports are filed for “PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION”, found by searching “PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Oct 27, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION POLITICAL ACTION COMMITTEE (PCMA PAC)
Filings covered
Through Sep 30, 2026
Data source
FEC bulk filing data
Pharmaceutical Care Management Association PAC is registered with the Federal Election Commission as a PAC (nonqualified). It is a lobbyist/registrant PAC. Its FEC record names Pharmaceutical Care Management Association as an affiliate. Official FEC summary: Federal Election Commission committee record.
Pages quoted 0 pages
No pages quoted
Nothing from this committee’s or its sponsor’s site is quoted yet.
Linked public records
No approved organization identity yet
The official FEC committee record remains available under Filings.
EBEric BurlisonRepublican · U.S. House · MO-07 · via Eric Burlison For Congress2 payments, latest Mar 24, 2026 · CONTRIBUTION · FEC filing, Mar 24, 2026$5K
$127.5K across 76 recipient committees, or 93% of everything this committee reports spending. The largest 12 are shown.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
Donors’ employers as filed
Donors’ employers
Employer as filed
Amount
Pharmaceutical Care Management Associa740 contributions · 78% of ranked
$69,050
Prime Therapeutics LLC2 contributions · 11% of ranked
$10,000
Optum RX2 contributions · 6.2% of ranked
$5,500
Waltz Health1 contribution · 2.3% of ranked
$2,000
Carelonrx1 contribution · 1.1% of ranked
$1,000
Humana INC1 contribution · 1.1% of ranked
$1,000
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($11,566) are not itemized, so no employer or occupation is filed for them.
Donors’ occupations as filed
Donors’ occupations
Occupation as filed
Amount
Executive431 contributions · 47% of ranked
$41,335
VP144 contributions · 19% of ranked
$17,018
CEO3 contributions · 17% of ranked
$15,000
AVP23 contributions · 5.7% of ranked
$5,050
President3 contributions · 4% of ranked
$3,500
SR DIR61 contributions · 3.4% of ranked
$3,033
SR Manager30 contributions · 1.4% of ranked
$1,200
Director50 contributions · 1.3% of ranked
$1,164
Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($11,566) are not itemized, so no employer or occupation is filed for them.
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.
Ensuring Community Access to Pharmacist Services Act S. 526;
Break Up Big Medicine Act H.R. 1244;
Reducing Drug Prices for Seniors Act H.R. 3164;
Ensuring Community Access to Pharmacist Service Act H.R. 4317;
Issues relating to pharmacy benefit managers;; H.R.2214 The DRUG Act; S.927 Protecting Pharmacies in Medicaid Act; S.1967 Patients Before Middlemen Act; S.864 HELP Copays Act; H.R.4317 PBM Reform Act of 2025
drug pricing, payment policy, and regulatory oversight
PBM Price Transparency and Accountability Act H.R. 4317;
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services S.4323/ H.R. 8143;
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)
Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 8143;